JAK1 and leukemia: This evidence clearly demonstrates from one side the relevance of STAT6 in sustaining leukemia cell proliferation, which is in good agreement also with the role of STAT6 in other types of cancer, such as colon and breast cancer [34] and, more generally, the contribution of the JAK1/2-STAT6 pathway to GC resistance.